tizanidine
- Product NDC
- 70710-1104
- 11-digit product format
- 707101104
- Labeler code
- 70710
- Product ID
- 70710-1104_eea72062-2a4b-4cc6-9b49-4bd709a689ee
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Zydus Pharmaceuticals (USA) Inc.
- Application
- ANDA208187
- Marketing category
- ANDA
- Marketing start
- 2018-09-13
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70710-1104-0 | 70710110400 | 1000 TABLET in 1 BOTTLE (70710-1104-0) | 1000 tablet | 2018-09-13 | 0000-00-00 | No | No | Current |
| 70710-1104-3 | 70710110403 | 30 TABLET in 1 BOTTLE (70710-1104-3) | 30 tablet | 2018-09-13 | 0000-00-00 | No | No | Current |
| 70710-1104-4 | 70710110404 | 10 BLISTER PACK in 1 CARTON (70710-1104-4) > 10 TABLET in 1 BLISTER PACK (70710-1104-2) | 10 blister pack | 2018-09-13 | 0000-00-00 | No | No | Current |
| 70710-1104-8 | 70710110408 | 150 TABLET in 1 BOTTLE (70710-1104-8) | 150 tablet | 2018-09-13 | 0000-00-00 | No | No | Current |